Inactive Instrument

Transcripts ImmunoGen, Inc.

Stocks

IMGN

US45253H1014

Biotechnology & Medical Research

Transcripts

02/11/23	ImmunoGen, Inc., Q3 2023 Earnings Call, Nov 02, 2023
31/07/23	ImmunoGen, Inc., Q2 2023 Earnings Call, Jul 31, 2023
03/05/23	ImmunoGen, Inc. - Special Call
28/04/23	ImmunoGen, Inc., Q1 2023 Earnings Call, Apr 28, 2023
01/03/23	ImmunoGen, Inc., 2022 Earnings Call, Mar 01, 2023
11/01/23	ImmunoGen, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-08-2023 through Jan-12-2023
15/11/22	ImmunoGen, Inc. - Special Call
04/11/22	ImmunoGen, Inc., Q3 2022 Earnings Call, Nov 04, 2022
04/11/22	ImmunoGen, Inc. Provides Earnings Guidance for the Year 2022	CI
28/09/22	ImmunoGen, Inc. Presents at 2022 Guggenheim Nantucket Therapeutics Conference, Sep-28-2022 11:15 AM
31/08/22	ImmunoGen, Inc. - Special Call
29/07/22	ImmunoGen, Inc., Q2 2022 Earnings Call, Jul 29, 2022
09/06/22	ImmunoGen, Inc. Presents at 2022 Jefferies Global Healthcare Conference, Jun-09-2022 09:30 AM
24/05/22	ImmunoGen, Inc. Presents at H.C. Wainwright Global Investment Conference 2022, May-24-2022 07:00 AM
06/05/22	ImmunoGen, Inc., Q1 2022 Earnings Call, May 06, 2022
06/05/22	Immunogen, Inc. Provides Revenue Guidance for 2022	CI
20/03/22	ImmunoGen, Inc. - Special Call
25/02/22	ImmunoGen, Inc., 2021 Earnings Call, Feb 25, 2022
25/02/22	ImmunoGen, Inc. Provides Earnings Guidance for the Year 2022	CI
12/01/22	ImmunoGen, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-12-2022 09:00 AM
30/11/21	ImmunoGen, Inc. - Special Call
29/10/21	ImmunoGen, Inc., Q3 2021 Earnings Call, Oct 29, 2021
29/10/21	ImmunoGen, Inc. Provides Updated Financial Guidance for 2021	CI
30/07/21	ImmunoGen, Inc., Q2 2021 Earnings Call, Jul 30, 2021
30/07/21	Immunogen, Inc. Maintains Revenue Guidance for the Year 2021	CI